Drug Type Antibody |
Synonyms NAV 1.7 |
Target |
Mechanism Nav1.7 blockers(Sodium channel protein type IX alpha subunit blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Abilita Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization Abilita Therapeutics, Inc.Startup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | US | Abilita Therapeutics, Inc.Startup | 06 Dec 2021 |